209 related articles for article (PubMed ID: 9892384)
1. Dialysis dose, membrane type, and anemia control.
Young EW
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
[TBL] [Abstract][Full Text] [Related]
2. Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure.
Ksiazek A; Baranowska-Daca E
Perit Dial Int; 1993; 13 Suppl 2():S550-2. PubMed ID: 8399662
[TBL] [Abstract][Full Text] [Related]
3. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
[TBL] [Abstract][Full Text] [Related]
4. Trends in anemia treatment with erythropoietin usage and patient outcomes.
Collins AJ; Ma JZ; Xia A; Ebben J
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S133-41. PubMed ID: 9892380
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin therapy in peritoneal dialysis patients.
Morris AT; Ronco C
Perit Dial Int; 2000; 20 Suppl 2():S178-82. PubMed ID: 10911666
[No Abstract] [Full Text] [Related]
6. Impact of erythropoietin on the dialysis prescription.
Van Wyck DB
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
[TBL] [Abstract][Full Text] [Related]
7. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
8. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
9. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
Baldamus CA; Steffen AM; Brunner R; Pollok M
Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
[No Abstract] [Full Text] [Related]
10. The clinical efficacy of higher hematocrit levels in children with chronic renal insufficiency and those undergoing dialysis.
Yorgin PD; Belson A; Al-Uzri AY; Alexander SR
Semin Nephrol; 2001 Sep; 21(5):451-62. PubMed ID: 11559886
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
[TBL] [Abstract][Full Text] [Related]
12. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
[No Abstract] [Full Text] [Related]
13. Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project.
Brem AS; Lambert C; Hill C; Kitsen J; Shemin DG
Am J Kidney Dis; 2000 Aug; 36(2):310-7. PubMed ID: 10922309
[TBL] [Abstract][Full Text] [Related]
14. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
Gallieni M
Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
[No Abstract] [Full Text] [Related]
15. The treatment of anemia with low-dose recombinant human erythropoietin.
Aronoff GR; Duff DR; Sloan RS; Brier ME; Maurice B; Erickson B; Golper TA
Am J Nephrol; 1990; 10 Suppl 2():40-3. PubMed ID: 2260617
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
Ongkingco JR; Ruley EJ; Turner ME; Fragale MR
Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
[TBL] [Abstract][Full Text] [Related]
17. Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients.
Granolleras C; Branger B; Deschodt G; Shaldon S; Nonnast-Daniel B; Pollok M
Contrib Nephrol; 1990; 82():49-54. PubMed ID: 2093526
[No Abstract] [Full Text] [Related]
18. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
19. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
Sinai-Trieman L; Salusky IB; Fine RN
J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients.
Volkova N; Arab L
Am J Kidney Dis; 2006 Jan; 47(1):24-36. PubMed ID: 16377382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
